2nd Quarter - Termination
WINNING STRATEGIES WASHINGTON for COYA THERAPEUTICS
Client
Income
$10,000
Expenses
—
Terminated
Jun 11, 2022
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Funding and other support for research and development of medical therapies, and support for policies that enhance patient access to medical therapies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NANCY FOX | Staff Director House Appropriations Committee, Chief of Staff Rep. Rodney Frelinghuysen (NJ) Scheduler Rep. Marge Roukema (NJ), Scheduler Rep. Silvio O. Conte (MA) |
| MICHAEL A MEROLA | Deputy CoS, Sen. Torricelli |
Medical/Disease Research/Clinical Labs MED
Funding and other support for research and development of medical therapies, and support for policies that enhance patient access to medical therapies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NANCY FOX | Staff Director House Appropriations Committee, Chief of Staff Rep. Rodney Frelinghuysen (NJ) Scheduler Rep. Marge Roukema (NJ), Scheduler Rep. Silvio O. Conte (MA) |
| MICHAEL A MEROLA | Deputy CoS, Sen. Torricelli |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.